Fabio Broglio
Overview
Explore the profile of Fabio Broglio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
1384
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bombonato M, Beccuti G, Benso A, Giannone B, Bertaina S, Broglio F, et al.
Hormones (Athens)
. 2025 Feb;
PMID: 39903441
Background: Sulfonylureas constitute the standard therapy for patients with HNF1A-MODY (maturity-onset diabetes of the young) but are characterized by an increased risk of hypoglycemia. While SGLT2 inhibitors (SGLT2i) may potentially...
2.
Zaccardi B, Armandi A, Caviglia G, Broglio F, Vernero M, Bombonato M, et al.
J Clin Med
. 2025 Jan;
14(1.
PMID: 39797226
The characterization of patients with inflammatory bowel disease (IBD) and type 2 diabetes mellitus (T2DM) as a new group has not been well detailed. This study aimed to evaluate the...
3.
Bioletto F, Ponzo V, Goitre I, Stella B, Rahimi F, Parasiliti-Caprino M, et al.
Nutrients
. 2024 Oct;
16(20).
PMID: 39458429
Objective: To assess the complementary role of the Body Mass Index (BMI) and Edmonton Obesity Staging System (EOSS) in predicting all-cause and cause-specific mortality in people living with overweight and...
4.
Beccuti G, Bioletto F, Parasiliti-Caprino M, Benso A, Ghigo E, Cicolin A, et al.
Curr Obes Rep
. 2024 Oct;
13(4):739-742.
PMID: 39378016
Purpose Of Commentary: This commentary aims to offer a perspective on the effect of tirzepatide on hypoxic burden and provide indirect evidence of cardiovascular risk reduction after tirzepatide for the...
5.
Olivieri C, Salato M, Campanella A, Marolo P, Parisi G, Neri G, et al.
Acta Diabetol
. 2024 Aug;
62(2):263-269.
PMID: 39160371
Purpose: To compare diabetic retinopathy screening among patients with type 1 or type 2 diabetes under care in two distinct setups: hospital-based multidisciplinary and general practice-based. Materials And Methods: In...
6.
Zizzi C, Dolla C, Fop F, Mella A, Sandrone M, Ghigo E, et al.
Kidney Int Rep
. 2024 Mar;
9(3):707-711.
PMID: 38481492
No abstract available.
7.
Egalini F, Rossi M, Massussi M, Gaggero G, Beccuti G, Benso A, et al.
Endocr Metab Immune Disord Drug Targets
. 2023 Dec;
24(6):651-663.
PMID: 38083891
In recent years, scientific research has increasingly focused on the cardiovascular benefits of omega-3 polyunsaturated fatty acids (n-3 PUFAs) supplements. The most promising results emerged from the new trials on...
8.
Egalini F, Guardamagna O, Gaggero G, Varaldo E, Giannone B, Beccuti G, et al.
Nutrients
. 2023 Jun;
15(12).
PMID: 37375575
Massive changes have occurred in our diet. A growing consumption of vegetal oils rich in omega-6 (ω-6) and a depletion of omega-3 (ω-3) fatty acids (FAs) in our food has...
9.
Viglino F, Sellami M, Broglio F, Scuntero P, Padovan A, Maulini C, et al.
J Pers Med
. 2022 Dec;
12(11).
PMID: 36579585
Background: Lipodystrophy is one of the most frequent complications in people with diabetes following subcutaneous insulin therapy, and poor management can lead to several problems, such as impaired glycemic control...
10.
Valenzano M, Bertolotti I, Grassi G, Broglio F, Valenzano A
J Diabetes Sci Technol
. 2022 Mar;
17(4):998-1007.
PMID: 35287492
Background: The adoption of continuous glucose monitoring (CGM) already helps to improve glycemic control in diabetes. When coupled with appropriate data analysis techniques, CGM also provides dependable estimates for significant...